Speculative at this point; but suffice it to say that GSK is on a buying spree and is aggressively looking to capture the Cancer-Therapy market. All signs seem to point to Dr. Axel Hoos (GSK and IMU); with the articles cited below, I have a strong feeling Axel will undoubtedly push for a GSK and IMU alliance. In the article cited below, it is evident that Dr. Axel has been seeking advice with JP Morgan on dealmaking - looks like this could be an IMU potential partnership since his association with both companies could drive the partnership to fruition. DYOR. JMHO. Good luck.
https://www.cancercareers.org/jobs/...y-clinical-development-at-glaxosmithkline-gsk
https://marketrealist.com/2018/01/g...-innovative-assets-oncology-research-pipeline
https://endpts.com/gsks-long-quiet-...se-as-it-mounts-a-breakout-late-stage-effort/
Speculative at this point; but suffice it to say that GSK is on...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.003(5.77%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.7¢ | 5.2¢ | $802.5K | 14.79M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 348447 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 1214875 | 6 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |